236. Pseudohypoparathyroidism Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 6 / Drugs : 5 - (DrugBank : 3) / Drug target genes : 20 - Drug target pathways : 28
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Recombinant human somatotropin
University of Milan
1995 - NCT00497484 Italy
Setmelanotide
Massachusetts General Hospital
2026 Phase 2 NCT07496463 United States
Theophylline
Vanderbilt University Medical Center
2020 Phase 2 NCT04551170 United States
2018 Phase 2 NCT03029429 United States
2015 Phase 2 NCT02463409 United States
Theophylline ER
Jaclyn Tamaroff
2020 Phase 2 NCT04240821 United States
University of Milan
1995 - NCT00497484 Italy
Setmelanotide
Massachusetts General Hospital
2026 Phase 2 NCT07496463 United States
Theophylline
Vanderbilt University Medical Center
2020 Phase 2 NCT04551170 United States
2018 Phase 2 NCT03029429 United States
2015 Phase 2 NCT02463409 United States
Theophylline ER
Jaclyn Tamaroff
2020 Phase 2 NCT04240821 United States
